Related Experiment Videos
[Sneddon's syndrome and Willebrand's factor antigen]
Klinicheskaia Meditsina
|January 1, 1994
Summary
Sneddon's syndrome patients showed elevated Willebrand factor antigen (WFA) in 33% of cases, suggesting potential endothelial damage contributing to thrombotic risk. Normal WFA levels may indicate other endothelial cell dysfunctions.
Area of Science:
- Neurology
- Vascular Biology
- Immunology
Context:
- Sneddon's syndrome is a rare condition characterized by cerebrovascular events and livedo reticularis.
- Investigating the role of endothelial dysfunction in Sneddon's syndrome is crucial for understanding thrombotic risk.
- Previous research has not fully elucidated the specific markers of endothelial damage in this syndrome.
Purpose:
- To assess Willebrand factor antigen (WFA) levels in patients with Sneddon's syndrome.
- To explore the correlation between elevated WFA and clinical manifestations or laboratory findings.
- To investigate the potential link between WFA levels and endothelial damage in Sneddon's syndrome.
Summary:
- Enzyme immunoassay for Willebrand factor antigen (WFA) was performed on 36 Sneddon's syndrome patients (25 female, 11 male, mean age 40).
- Elevated WFA (>2 IU/ml) was observed in 12 patients (33%).
- No significant differences in clinical features, severity, antiphospholipid antibodies, or CIC levels were found between patients with normal and elevated WFA.
Impact:
- Findings suggest that elevated WFA in Sneddon's syndrome may indicate structural endothelial damage contributing to thrombotic risk.
- Normal WFA levels might imply alternative mechanisms of endothelial cell dysfunction.
- This study highlights WFA as a potential biomarker for assessing endothelial integrity in Sneddon's syndrome.